Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular testing in malignant melanoma.

Diagnostic cytopathology - 1 Jun 2012

Grossmann Allie H, Grossmann Kenneth F, Wallander Michelle L

Abstract excerpt

Molecular testing of cancers to determine therapeutic eligibility is now standard of care and has changed the practice of pathology. Recent advances in the treatment of metastatic melanoma with BRAF and KIT inhibitors have increased the demand for molecular testing in melanoma. Furthermore, rapid progress is being made in determining potential new targets, mechanisms of resistance, and developing additional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Melanoma
Share to Pathology, Molecular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins c-kit

Share to Receptor, ErbB-4

Share to Skin Neoplasms

Source

Identifiers

PMID: 22619125
DOI: 10.1002/dc.22810

Genes

BRAF
KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular testing in malignant melanoma.PMID 22619125Read ↗

Molecular testing in melanoma.Semantic proximity Read ↗

New strategies in melanoma: molecular testing in advanced disease.Semantic proximity Read ↗

The Current State of Molecular Testing in the BRAF-Mutated Melanoma LandscapeSemantic proximity Read ↗

Genetic Testing in the Multidisciplinary Management of Melanoma.Semantic proximity Read ↗

Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicineSemantic proximity Read ↗

Current Molecular Markers of Melanoma and Treatment Targets.Semantic proximity Read ↗

[Molecular diagnostics in melanoma].Semantic proximity Read ↗

Using Genomic Sequencing to Improve Management in Melanoma.Semantic proximity Read ↗

The Future of Molecular Analysis in Melanoma: Diagnostics to Direct Molecularly Targeted Therapy.Semantic proximity Read ↗

Analysis of the genome to personalize therapy for melanoma.Semantic proximity Read ↗

Genetic alterations and personalized medicine in melanoma: progress and future prospects.Semantic proximity Read ↗

BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.